Faculty profile

Santiago Perez Patrigeon

ResearcherMedicineMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses and email address may be missing. Find their university profile.

Santiago Perez Patrigeon

Researcher

Medicine

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
1 publication in the last five years, latest in 2022.
Principal investigator on 1 research grant (1 CIHR), most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

173

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

C. Difficile Clostridioides Difficile Infection Diarrhea Fidaxomicin Nosocomial Infection Placebo Controlled Platform Trial Randomized Controlled Trial

Latest papers

Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial
CANADIAN MEDICAL ASSOCIATION JOURNAL · 2022

All 1 publications

Latest funding

Strategies for the Treatment and Prevention of Recurrent Clostridioides difficile infection: The SPORES Platform
CIHR · 2025 · Principal investigator
$2,015,775
Clopidogrel vs. Aspirin in S. aureus Bacteremia (Clopido-SNAP)
CIHR · 2024 · Co-investigator
$539,325
Dabigatran for the adjunctive treatment of Staphylococcus aureus bacteremia: the DABI-SNAP nested randomized controlled trial
CIHR · 2024 · Co-investigator
$539,325

All 9 grants and awards

Strategies for the Treatment and Prevention of Recurrent Clostridioides difficile infection: The SPORES Platform

Principal investigatorCIHR2025Project Grant

Principal investigators: McDonald, Emily G; Carignan, Alex; Chan, Adrienne; Chen, Yan; Daley, Peter; Daneman, Nick; Kandel, Christopher; Lee, Todd C; Longtin, Yves; Perez Patrigeon, Santiago; Wuerz, Terence

Keywords: C. Difficile; Clostridioides Difficile Infection; Diarrhea; Fidaxomicin; Nosocomial Infection; Placebo Controlled; Platform Trial; Randomized Controlled Trial; Recurrence; Vancomycin

$2,015,775

Clopidogrel vs. Aspirin in S. aureus Bacteremia (Clopido-SNAP)

Co-investigatorCIHR2024Project Grant

Principal investigators: Lee, Todd C; Cheng, Matthew P; Daneman, Nick; Davis, Joshua; Goodman, Anna L; Lawler, Patrick R; McDonald, Emily G; Mertz, Dominik; Paul, Mical; Siegal, Deborah M; Tong, Steven; Walls, Genevieve

Keywords: Antithrombotic Therapy; Bacteremia; Randomized Controlled Trial; Staphylococcus Aureus

$539,325

Dabigatran for the adjunctive treatment of Staphylococcus aureus bacteremia: the DABI-SNAP nested randomized controlled trial

Co-investigatorCIHR2024Project Grant

Principal investigators: McDonald, Emily G; Cheng, Matthew P; Daneman, Nick; Davis, Joshua; Goodman, Anna L; Lawandi, Alexander; Lawler, Patrick R; Lee, Todd C; Mertz, Dominik; Paul, Mical; Siegal, Deborah M; Tong, Steven; Walls, Genevieve

Keywords: Adjunctive Therapies; Anticoagulants; Comparative Effectiveness Trial; Desirability Of Ordinal Outcomes Rating; Infectious Diseases; Nested Trials; Platform Trial; Pragmatic Trials; Staph Aureus Bacteremia

$539,325

A Randomized Controlled Trial of Oral Antimicrobial Therapy for Patients with Staphylococcus aureus Bacteremia: The Early Oral Switch Domain in the Staphylococcus aureus Network Adaptive Trial (EOS-SNAP)

Co-investigatorCIHR2024Project Grant

Principal investigators: Cheng, Matthew P; Bai, Anthony D; Daley, Peter; Daneman, Nick; Grant, Jennifer; Lawandi, Alexander; Lee, Todd C; MacFadden, Derek R; McDonald, Emily G; Somayaji, Ranjani; Wuerz, Terence

Keywords: Bacteremia; Bloodstream Infection; Clinical Trial; Oral Antibiotics; Staphylococcus Aureus

$1,705,952

Expanding the Staphylococcus Aureus Network Adaptive Platform (SNAP^2)

Co-investigatorCIHR2022Operating Grant: Clinical Trials Projects

Principal investigators: Lee, Todd C; Cheng, Matthew P; Daneman, Nick; Davis, Joshua; Goodman, Anna L; Johnstone, Jennie; Lawandi, Alexander; Lye, David C; McDonald, Emily G; Paul, Mical; Tong, Steven; Walls, Genevieve; Wuerz, Terence

Keywords: Combination Therapy; Endocarditis; Randomized Controlled Trial; Staphylococcus Aureus Bacteremia

$1,999,745

Expanding the Staphylococcus Aureus Network Adaptive Platform (SNAP^2)

Co-investigatorCIHR2022Operating Grant: Clinical Trials Projects - Indirect Costs

Keywords: Combination Therapy; Endocarditis; Randomized Controlled Trial; Staphylococcus Aureus Bacteremia

$499,936

CATCO Scale-Up COVID-19 Supplement - Canadian Treatments for COVID-19: SOLIDARITY

Co-investigatorCIHR2021Operating Grant: CATCO Scale-Up COVID-19 Supplement Funding Opportunity

Principal investigators: Murthy, Srinivas; Fowler, Robert A

Keywords: Clinical Characterization; Knowledge Translation; Randomized Clinical Trial; Stakeholder Perspectives

$3,500,000

HOST RESPONSE MEDIATORS IN CORONAVIRUS (COVID-19) INFECTION - IS THERE A PROTECTIVE EFFECT OF ARBs ON OUTCOMES OF CORONAVIRUS INFECTION? (ARBs CORONA II)

Co-investigatorCIHR2020Operating Grant: COVID-19 Rapid Research Funding Opportunity - Therapeutics

Principal investigators: Russell, James A

Keywords: Arbs; Biomarkers; Covid-19; Host Response; Losartan; Randomized Controlled Trial

$3,456,541

COVID-19: Improving the Evidence to Treat an Emerging Infection Through Observational Studies and a Randomized Trial

Co-investigatorCIHR2020Operating Grant: COVID-19 - Clinical management

Principal investigators: Murthy, Srinivas; Amuasi, John; Fowler, Robert A

Keywords: Clinical Characterization; Knowledge Translation; Randomized Clinical Trial; Stakeholder Perspectives

$954,936

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Santiago Perez Patrigeon

Research

Latest papers

Latest funding

Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial

Strategies for the Treatment and Prevention of Recurrent Clostridioides difficile infection: The SPORES Platform

Clopidogrel vs. Aspirin in S. aureus Bacteremia (Clopido-SNAP)

Dabigatran for the adjunctive treatment of Staphylococcus aureus bacteremia: the DABI-SNAP nested randomized controlled trial

A Randomized Controlled Trial of Oral Antimicrobial Therapy for Patients with Staphylococcus aureus Bacteremia: The Early Oral Switch Domain in the Staphylococcus aureus Network Adaptive Trial (EOS-SNAP)

Expanding the Staphylococcus Aureus Network Adaptive Platform (SNAP^2)

Expanding the Staphylococcus Aureus Network Adaptive Platform (SNAP^2)

CATCO Scale-Up COVID-19 Supplement - Canadian Treatments for COVID-19: SOLIDARITY

HOST RESPONSE MEDIATORS IN CORONAVIRUS (COVID-19) INFECTION - IS THERE A PROTECTIVE EFFECT OF ARBs ON OUTCOMES OF CORONAVIRUS INFECTION? (ARBs CORONA II)

COVID-19: Improving the Evidence to Treat an Emerging Infection Through Observational Studies and a Randomized Trial

Frequent collaborators

Cecilia Costiniuk

Alexis Turgeon

Wendy Sligl

Michael Silverman

Michael Silverman

Jennifer Tsang

Stephen Giilck

Erick Duan

Sergio Borgia

Karim Ali

Ryan Zarychanski

Alexis Turgeon

Marina Klein

Francois Lamontagne

Marina Klein

Nick Daneman

Shane English

Alexis Turgeon

Patricia Fontela

Cecilia Costiniuk

Srinivas Murthy

John Conly

Makeda Semret

Madeleine Durand

Marina Klein